| BIOMARIN PHAR. DL-,001 |
| USA |
| Gesundheit |
| US09061G1013 / 924801 |
| BM8 (Frankfurt) / BMRN (NASDAQ) |
| FRA:BM8, ETR:BM8, BM8:GR, NASDAQ:BMRN |
| - |
| https://www.biomarin.com/ |
|
BioMarin Pharmaceutical Inc. is a leading biotechn..
>Volltext.. |
| 8487.55 Mio. EUR |
| 7748.03 Mio. EUR |
| 2631.22 Mio. EUR |
| 800.16 Mio. EUR |
| 443.86 Mio. EUR |
| 2.32 EUR |
| 521.27 Mio. EUR |
| 1066.2 Mio. EUR |
| 779.52 Mio. EUR |
| 1.85 |
| 6.57% |
| 53.21% |
| - |
| - |
| - |
| - |
| BIOMARIN |
| 19.12.25 |
|
||||
|